Not available
Quote | BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
Last: | $84.59 |
---|---|
Change Percent: | -0.08% |
Open: | $85.66 |
Close: | $84.59 |
High: | $86.45 |
Low: | $84.07 |
Volume: | 1,063,385 |
Last Trade Date Time: | 07/26/2024 03:00:00 am |
News | BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
2024-07-24 16:47:21 ET More on BioMarin Pharmaceutical BioMarin Pharmaceutical: Steady Performer Scheduling Its Big Reveal In 09/2024 BioMarin: Short-Term Headwinds But Long-Term Opportunities Remain BMO sees BMRN, LEGN, SLN as attractive M&A targets Thir...
U.S. Food and Drug Administration Approves BioMarin's BRINEURA® (cerliponase alfa) for Children Under 3 Years with CLN2 Disease PR Newswire Now Approved for Children of All Ages with CLN2 Batten Disease, Regardless of Whether They Yet Show Symptoms SAN RAFAEL, C...
Message Board Posts | BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
Subject | By | Source | When |
---|---|---|---|
whytestocks: $BMRN News Article - BioMarin Announces Advancements in FDA Review of ROCTAVIAN(TM) (Va | whytestocks | investorshangout | 11/23/2022 2:55:51 PM |
GRABAR LAW OFFICE INVESTIGATES POTENTIAL DERIVATIVE ACTION ON | jgrabar | investorshub | 04/11/2022 3:40:15 PM |
whytestocks: $BMRN News Article - Shares of BioMarin Pharmaceutical Inc. (BMRN) Rise to a New 52-Wee | whytestocks | investorshangout | 04/08/2022 5:40:51 PM |
whytestocks: $BMRN News Article - BioMarin Pharmaceutical inc (BMRN) Q3 2021 Earnings Call Transcrip | whytestocks | investorshangout | 10/28/2021 6:55:58 PM |
whytestocks: $BMRN News Article - European Commission Approves BioMarin's VOXZOGO (vosoritide) for t | whytestocks | investorshangout | 08/27/2021 3:05:59 PM |
News, Short Squeeze, Breakout and More Instantly...
BioMarin Pharmaceutical Inc. Company Name:
BMRN Stock Symbol:
NASDAQ Market:
BioMarin Pharmaceutical Inc. Website:
U.S. Food and Drug Administration Approves BioMarin's BRINEURA® (cerliponase alfa) for Children Under 3 Years with CLN2 Disease PR Newswire Now Approved for Children of All Ages with CLN2 Batten Disease, Regardless of Whether They Yet Show Symptoms SAN RAFAEL, C...
BioMarin to Host Second Quarter 2024 Financial Results Conference Call and Webcast on Monday, August 5, 2024, at 4:30pm ET PR Newswire SAN RAFAEL, Calif. , July 23, 2024 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Alexander ...
2024-07-10 03:22:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...